Evidence map›Paper›PMID 29488462›Full record

ArticleThe American journal of tropical medicine and hygiene2018

"

Temmy Sunyoto, Gamal K Adam, Atia M Atia, Yassin Hamid, Rabie Ali Babiker, Nugdalla Abdelrahman, Catiane Vander Kelen, Koert Ritmeijer, Gabriel Alcoba, Margriet den Boer and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. New Phosphoramidates Containing Selenium as Leishmanicidal Agents.Antimicrobial agents and chemotherapy · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Temmy SunyotoInstitute of Tropical Medicine, Antwerp, Belgium.
Gamal K AdamFaculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan.
Atia M AtiaFaculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan.
Yassin HamidFaculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan.
Rabie Ali BabikerFaculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan.
Nugdalla AbdelrahmanFaculty of Medicine, Kala-Azar Research Center, University of Gadarif, Al Qadarif, Sudan.
Catiane Vander KelenInstitute of Tropical Medicine, Antwerp, Belgium.
Koert RitmeijerMédecins Sans Frontières, Amsterdam, The Netherlands.
Gabriel AlcobaMédecins Sans Frontières, Geneva, Switzerland.
Margriet den BoerKalaCORE Consortium, London, United Kingdom.
Albert PicadoISGlobal, Barcelona Institute of Global Health, Barcelona, Spain.
Marleen BoelaertInstitute of Tropical Medicine, Antwerp, Belgium.
Gadarif University · SDInstituut voor Tropische Geneeskunde · BEMédecins Sans Frontières · NLMédecins Sans Frontières · CHBarcelona Institute for Global Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis and treatment is the principal strategy to control visceral leishmaniasis (VL), or kala-azar in East Africa. As VL strikes remote rural, sparsely populated areas, kala-azar care might not be accessed optimally or timely. We conducted a qualitative study to explore access barriers in a longstanding kala-azar endemic area in southern Gadarif, Sudan. Former kala-azar patients or caretakers, community leaders, and health-care providers were purposively sampled and thematic data analysis was used. Our study participants revealed the multitude of difficulties faced when seeking care. The disease is well known in the area, yet misconceptions about causes and transmission persist. The care-seeking itineraries were not always straightforward: "shopping around" for treatments are common, partly linked to difficulties in diagnosing kala-azar. Kala-azar is perceived to be "hiding," requiring multiple tests and other diseases must be treated first. Negative perceptions on quality of care in the public hospitals prevail, with the unavailability of drugs or staff as the main concern. Delay to seek care remains predominantly linked to economic constraint: albeit treatment is for free, patients have to pay out of pocket for everything else, pushing families further into poverty. Despite increased efforts to tackle the disease over the years, access to quality kala-azar care in this rural Sudanese context remains problematic. The barriers explored in this study are a compelling reminder of the need to boost efforts to address these barriers.

Indexed as

Health Services AccessibilityAdolescentAdultAgedFemaleHumansLeishmaniasis, VisceralMaleMiddle AgedPatient Acceptance of Health CarePovertySudanYoung Adult

Identifiers

PMID29488462
PMCPMC5928836
OpenAlexW2792999069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.